Publications by authors named "Belen De Frutos Gonzalez"
Introduction: Regorafenib is indicated as treatment in third-line and beyond in patients with metastatic colorectal cancer.
Methods: This is a retrospective study of a cohort of patients with mCRC treated with regorafenib in Hospital Universitario Ramón y Cajal, in Madrid, Spain.
Results: With the aim to assess the efficacy and safety of regorafenib, 91 patients treated between 2013 and 2023 were included.
Article Synopsis
- Extrapulmonary small-cell carcinoma (SCC) is a rare and aggressive type of cancer, mainly found in the gastrointestinal tract, and is often diagnosed late with limited treatment options.
- A case study highlights a 77-year-old Spanish man with localized SCC of the colon who achieved a complete pathological response after receiving chemotherapy with cisplatin and etoposide before surgery.
- Five years post-surgery, he has shown no signs of cancer recurrence, prompting a review of existing literature due to the absence of standardized clinical guidelines for managing this condition.